Synonym |
Zoladex |
Species |
Human |
Protein Accession |
P30968 |
Purity |
Greater than 95% as determined by RP-HPLC |
Endotoxin Level |
Less than 1 EU/μg as determined by LAL method |
Biological Activity |
Not specified |
Expression System |
Escherichia coli |
Fusion Tag |
GST tag |
Predicted Molecular Mass |
12.5 kDa |
Formulation |
Lyophilized from a 0.2 μm filtered solution in PBS |
Reconstitution |
Centrifuge the vial prior to opening. Reconstitute in sterile PBS, pH 7.4 to a concentration of
1 mg/ml. Do not vortex. |
Storage & Stability |
Store lyophilized protein at -20°C. Reconstituted protein should be stored at 4°C and used
within 3 months. |
FAQ
What is Goserelin acetate and how does it work in the body?
Goserelin acetate is a synthetic analog
of the naturally occurring luteinizing hormone-releasing hormone (LHRH). This medication is classified
as a type of gonadotropin-releasing hormone (GnRH) agonist and is primarily utilized in the treatment of
hormone-sensitive cancers, such as prostate cancer and breast cancer, as well as certain other
conditions that are influenced by sex hormones. The way Goserelin acetate functions is by influencing
the pituitary gland, which is responsible for producing hormones that regulate testosterone and estrogen
levels in the body. By administering Goserelin acetate, the body undergoes an initial increase in the
production of these hormones, followed by a significant decrease. This is known as "chemical castration"
because it reduces hormone levels to a very low state, similar to that which would be achieved after
surgical removal of the ovaries or testes. In men, the continuous administration of Goserelin acetate
eventually decreases the production of testosterone, a hormone that can fuel the growth of prostate
cancer. Similarly, in women, the reduction of estrogen levels is critical in slowing down or inhibiting
the growth of certain breast cancers. Moreover, the medication is used in managing endometriosis by
reducing estrogen and thus the growth of endometrial tissue. The decreased hormone levels induced by
Goserelin acetate can help in reducing tumor sizes, alleviating symptoms, and delaying disease
progression. It’s crucial to understand that Goserelin acetate is delivered via a predictable and
sustained-release injectable formulation, typically administered in a healthcare setting. The use of
Goserelin acetate is a nuanced process, and patients undergoing treatment with this medication are
typically monitored closely by healthcare professionals due to the profound effects hormonal alterations
can have on bodily functions. It is important to have a consultation with a healthcare provider to
evaluate the potential benefits and risks associated with this therapy, while also beginning any
necessary supplementary treatments to manage side effects associated with hormonal
fluctuations.
Why is Goserelin acetate used in cancer treatment, and what types of cancer does it
treat?
Goserelin acetate plays a critical role in oncological treatment primarily due to its ability
to modulate hormonal levels in the body, which is a pivotal factor in the management of
hormone-sensitive cancers. One of its primary applications is in the treatment of advanced prostate
cancer. Prostate cancer cells are often dependent on male hormones, specifically testosterone, for
growth and proliferation. Goserelin acetate effectively reduces the levels of testosterone produced by
the body, thereby starving the cancer cells of the hormone they rely on, which can lead to reduced tumor
growth or even reduction in size. Additionally, Goserelin acetate is utilized in the management of
breast cancer in premenopausal women. Certain types of breast cancer are estrogen receptor-positive,
meaning they require estrogen to grow. By administering Goserelin acetate, estrogen levels are lowered
significantly, which may help slow or halt the growth of cancer cells. This form of hormonal therapy is
often used as part of a broader treatment plan that may include surgery, radiation, and chemotherapy,
helping improve survival rates and quality of life for breast cancer patients. Beyond its use in
prostate and breast cancer, Goserelin acetate is also beneficial for treating conditions like
endometriosis, where the reduction of estrogen can help manage symptoms by minimizing the growth of
endometrial tissue outside the uterus. In addition to treating various cancers, Goserelin acetate may be
prescribed to manage uterine fibroids and used as part of fertility treatments to regulate hormone
levels. The decision to employ Goserelin acetate is typically based on several factors, including the
type and stage of cancer, patient health, and treatment goals. Specialists in oncology employ Goserelin
acetate as part of a comprehensive, multidisciplinary approach to cancer care, often when other
hormone-blocking therapies are warranted or when surgical castration is not a viable option.
What
are the common side effects associated with Goserelin acetate treatment?
Patients undergoing
treatment with Goserelin acetate should be aware of the various side effects that can accompany its use,
as the medication profoundly impacts hormonal levels within the body. A wide array of side effects are
possible, ranging from mild to severe, and can vary based on individual patient factors and whether the
patient is male or female. One of the more common adverse effects for both men and women is the
experience of hot flashes; these are sudden periods of intense warmth, flushing, and sweating due to the
body's response to altered hormone levels. Other general side effects can include headache, dizziness,
nausea, mood swings, and increased sweating. Erectile dysfunction and reduced libido are also frequently
reported among male patients, with men also experiencing a risk for bone density loss, which can lead to
osteoporosis over long-term usage. Goserelin acetate can also cause an initial increase in hormone
levels, known as "flare," that might temporarily exacerbate symptoms of prostate cancer, such as bone
pain or difficulty urinating. For women, menstrual cycle changes are common, where some may experience
irregular periods at first, which may eventually cease altogether due to lowered estrogen levels. Women
can also experience vaginal dryness, breast tenderness, decreased libido, and mood changes. An important
consideration for women is the extended use of Goserelin acetate leading to decreased bone density,
especially if used continuously over an extended period without breaks. Apart from these, site reactions
can occur at the injection area, which might include redness, pain, or swelling. Considering the
extensive list of potential side effects, it is critical for patients to communicate regularly with
their healthcare providers to manage any complications or discomfort resulting from treatment.
Healthcare providers may recommend lifestyle changes, dietary supplements, or medications to help
mitigate these side effects and optimize the patient’s quality of life during treatment. Close
monitoring and regular follow-ups are imperative to address these side effects appropriately and make
necessary adjustments to the treatment regimen.
How should Goserelin acetate be administered, and
what should patients expect during administration?
Goserelin acetate is typically administered via a
subcutaneous implant, which is a small pellet injected under the skin, usually in the abdominal area.
The administration of Goserelin acetate is conducted in a healthcare setting by a trained professional,
ensuring that the implant is placed correctly and safely. There are two common dosing regimens
available: a monthly dose or a longer-term three-month dose, depending on the specific needs of the
patient and the condition being treated. During the administration process, patients may experience mild
discomfort or pain at the injection site, and there might be a localized reaction characterized by
redness, swelling, or bruising. Given that Goserelin acetate is a treatment that influences hormone
production, patients should be prepared for potential side effects earlier in the treatment regime.
After the initial administration, patients might experience a "flare reaction," where symptoms
temporarily intensify due to the initial surge in hormone levels before the full suppressive effects of
the treatment take hold. In anticipation of this, doctors might prescribe additional medications to help
manage these symptoms. Following the injection, patients are generally monitored to ensure there are no
immediate adverse reactions, and they are provided with guidance on what post-administration symptoms to
watch for. Patients should adhere strictly to their appointment schedules for subsequent doses, as
maintaining consistent hormone suppression is crucial for the effectiveness of the treatment. Patients
will often undergo regular assessments to evaluate how well the treatment is working and whether any
adjustments to the regimen are necessary. This may include blood tests to monitor hormone levels,
imaging tests to assess cancer progression or regression, and periodic evaluations of overall health and
well-being. It is crucial for patients to maintain open communication with their healthcare team
throughout the treatment process, reporting any side effects or concerns promptly. This ongoing dialogue
helps optimize treatment outcomes and ensure patient safety and comfort while managing the underlying
condition being treated with Goserelin acetate.
What precautions should be taken by patients
considering Goserelin acetate therapy?
Before initiating Goserelin acetate therapy, patients must
undergo a thorough medical evaluation by their healthcare provider to ascertain the appropriateness of
this treatment for their specific health condition. It is essential that patients disclose their
complete medical history, including any other health issues or chronic conditions they may be
experiencing, such as cardiovascular disease, diabetes, liver or kidney impairment, or osteoporosis.
Special attention should be given to any history of depression, as hormonal changes induced by Goserelin
acetate can potentially exacerbate mood disorders. Allergic reactions to Goserelin or similar
medications should be reported, as they may contraindicate the use of this medication. Additionally, due
to the medication's potential to impact bone density adversely, especially with long-term use, patients
with a history of osteoporosis or other bone health issues should discuss the risk-benefit ratio of the
treatment with their doctor, who may recommend bone density testing as part of the treatment protocol.
Female patients, in particular, should be aware that the medication can affect menstrual cycles and
impact bone density. As such, it may be beneficial for women to consider non-hormonal methods of
contraception to prevent pregnancy during treatment, since Goserelin acetate can cause harm to the
fetus. Patients are advised to review all medications they're currently taking with their healthcare
provider to avoid drug interactions, which could diminish the efficacy of Goserelin acetate or
exacerbate side effects. During the treatment, regular follow-up appointments are necessary to monitor
the effectiveness of the therapy and to manage any arising side effects adequately. Patients should be
vigilant in reporting any unexpected or severe side effects, particularly those that affect daily
functioning or quality of life. Understanding and discussing these precautions with healthcare providers
empowers patients to make informed decisions about their cancer treatment and allows for proactive
management of any complications that could arise during therapy. It's also wise for patients to maintain
a balanced diet, engage in regular physical activity when possible, and access support services such as
counseling or support groups to help them navigate the emotional and physical demands of their treatment
journey.
Can Goserelin acetate be used in combination with other treatments, and what are the
potential benefits and considerations?
Goserelin acetate can indeed be utilized in conjunction with
other treatments, often as part of a comprehensive therapeutic approach to managing hormone-sensitive
cancers. Combining therapies is a tactic used to enhance the overall effectiveness of cancer treatment,
address different aspects of disease progression, and improve patient outcomes. In prostate cancer, for
instance, Goserelin acetate is frequently used alongside anti-androgens, which are medications that
block testosterone from binding to cancer cells, thereby further suppressing cancer growth. This
combination can be particularly beneficial when the aim is to manage advanced prostate cancer more
effectively and potentially delay disease progression. Additionally, for patients with locally advanced
or metastatic prostate cancer, combining Goserelin acetate with radiation therapy has shown increased
efficacy in controlling tumor growth and enhancing survival rates compared to when either modality is
used alone. Similarly, in breast cancer treatment for premenopausal women, Goserelin acetate might be
paired with medications like tamoxifen, which blocks estrogen receptors on cancer cells, thus inhibiting
cancer growth fueled by estrogen. When conceiving a treatment plan that involves Goserelin acetate in
conjunction with other modalities, it's crucial to consider the potential for increased side effects due
to multiple therapies. The cumulative impacts might necessitate more intensive management strategies to
mitigate side effects such as fatigue, hormonal disturbances, and gastrointestinal issues. Careful
coordination and monitoring by the healthcare team are vital to fostering therapeutic efficacy while
managing adverse reactions. For patients, understanding the rationale behind combination therapies helps
them remain engaged and informed participants in their healthcare journey. Discussions with oncologists
about the potential benefits and risks associated with combination therapy are crucial, enabling
personalized treatment plans that align with the patient's specific medical needs and lifestyle
considerations. Additionally, ongoing research continues to explore and optimize the role of Goserelin
acetate within combination therapies, potentially revealing new synergies and avenues for enhanced
cancer treatment in the future. Ultimately, the decision to employ Goserelin acetate in multi-modal
treatment regimens is made collaboratively between the patient and their healthcare team, guided by the
latest research and clinical evidence tailored to individual patient profiles.
What should
patients know about the potential long-term effects of Goserelin acetate treatment?
Goserelin
acetate, due to its profound influence on hormonal balance, can have a number of long-term effects,
which are pivotal considerations for patients undergoing extended treatment. One of the significant
long-term implications is its impact on bone health. As the medication lowers sex hormone levels, it can
lead to decreased bone mineral density, increasing the risk for osteoporosis, especially in prolonged
usage scenarios. This is a particular concern for women and men who are using Goserelin acetate for an
extended period, making it important for patients to engage in regular bone density monitoring and
possibly take supplements like calcium and vitamin D or medications that help maintain bone strength
under the guidance of their healthcare provider. Cardiometabolic effects are another area of concern, as
the medication can affect lipid profiles and glucose metabolism. There is an associated risk for
developing conditions such as diabetes or cardiovascular disease due to the metabolic changes induced by
the therapy. Patients should therefore maintain regular check-ups focusing on heart health and undergo
periodic assessments of blood sugar levels and lipid panels to catch and address any emerging issues
early. Additionally, weight gain and changes in body composition can occur, necessitating lifestyle
adjustments to ensure maintenance of a healthy weight through diet and exercise. Emotional and
psychological effects must also be acknowledged. Long-term use of Goserelin acetate can cause mood
shifts, anxiety, or depression, requiring that patients have supportive measures in place, such as
counseling or support groups, to help manage emotional well-being. Moreover, the sexual side effects of
decreased libido and potential sexual dysfunction can persist, impacting relationships and quality of
life. Open dialogue with healthcare providers allows for tailored interventions to address both physical
and emotional changes associated with Goserelin acetate use. Patients should advocate for themselves,
seeking comprehensive care that includes both medical management and supportive services to navigate the
long-term effects of treatment. Ultimately, while Goserelin acetate is effective in managing certain
cancers, understanding its long-term impacts allows patients and healthcare providers to proactively
manage these effects, maximizing treatment benefits while minimizing negative outcomes on patient health
and quality of life.